Updates on CCP Virus: FDA Authorizes Johnson & Johnson Single Dose Vaccine
The Food and Drug Administration on Saturday authorized Johnson & Johnson’s single-dose adenovirus vector COVID-19 vaccine for adults aged 18 and older following Friday’s unanimous endorsement by the agency’s panel of outside experts.
In J&J’s 44,000-person global trial, the vaccine was found to be 66 percent effective at preventing moderate-to-severe COVID-19 four weeks after inoculation, and 100 percent effective in preventing hospitalization and death due to the virus.
There were very few serious side effects reported in the trial, which also offered preliminary evidence that the vaccine reduced asymptomatic infections. If that proves to be the case, it would mean COVID-19 vaccines may indeed reduce virus transmission as well as illness.
Updates on CCP Virus: Lockdown Interferes With Fundamental Human Rights, Says UK Conservative
The lockdown measures adopted to contain the CCP virus have interfered with fundamental human rights, a senior British Conservative politician told NTD.
Sir Graham Brady, chairman of the influential 1922 Committee of Conservative MPs, welcomed the UK government’s plan to take the country out of the ongoing national lockdown, calling it a “step forward.” But he said the pace of the planned exit is “slower than many of us would have liked” and “slower than the data would suggest is possible.”
Lung Transplant Can Transmit Virus
The CCP (Chinese Communist Party) virus can linger in the lungs even when swab tests of the back of the nose and throat are negative, doctors reported after unknowingly transplanting infected lungs into a patient who later died of COVID-19, the disease caused by the CCP virus.
The UK government defended its recommendation that secondary pupils should wear face coverings inside classrooms when they return to school next month.